563 related articles for article (PubMed ID: 25970242)
41. Pre-mRNA splicing alters mRNP composition: evidence for stable association of proteins at exon-exon junctions.
Le Hir H; Moore MJ; Maquat LE
Genes Dev; 2000 May; 14(9):1098-108. PubMed ID: 10809668
[TBL] [Abstract][Full Text] [Related]
42. In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.
Blázquez L; Aiastui A; Goicoechea M; Martins de Araujo M; Avril A; Beley C; García L; Valcárcel J; Fortes P; López de Munain A
Hum Mutat; 2013 Oct; 34(10):1387-95. PubMed ID: 23864287
[TBL] [Abstract][Full Text] [Related]
43. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells.
Listerman I; Sapra AK; Neugebauer KM
Nat Struct Mol Biol; 2006 Sep; 13(9):815-22. PubMed ID: 16921380
[TBL] [Abstract][Full Text] [Related]
44. A novel intron element operates posttranscriptionally To regulate human N-myc expression.
Sivak LE; Pont-Kingdon G; Le K; Mayr G; Tai KF; Stevens BT; Carroll WL
Mol Cell Biol; 1999 Jan; 19(1):155-63. PubMed ID: 9858540
[TBL] [Abstract][Full Text] [Related]
45. The RNA methyltransferase Misu (NSun2) mediates Myc-induced proliferation and is upregulated in tumors.
Frye M; Watt FM
Curr Biol; 2006 May; 16(10):971-81. PubMed ID: 16713953
[TBL] [Abstract][Full Text] [Related]
46. Nuclear targeting of antisense oligonucleotides: modification of PRE-mRNA splicing or inhibition of polyadenylation?
Tomasi V; Spisni E; Griffoni C; Santi S
Nucleosides Nucleotides; 1998; (9-11):2073-80. PubMed ID: 12683389
[No Abstract] [Full Text] [Related]
47. Deficiency in the DNA glycosylases UNG1 and OGG1 does not potentiate c-Myc-induced B-cell lymphomagenesis.
Green B; Martin A; Belcheva A
Exp Hematol; 2018 May; 61():52-58. PubMed ID: 29496532
[TBL] [Abstract][Full Text] [Related]
48. Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis.
Potts MA; Mizutani S; Garnham AL; Li Wai Suen CSN; Kueh AJ; Tai L; Pal M; Strasser A; Herold MJ
Cell Death Differ; 2023 Jun; 30(6):1447-1456. PubMed ID: 36894688
[TBL] [Abstract][Full Text] [Related]
49. PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells.
Tan DQ; Li Y; Yang C; Li J; Tan SH; Chin DWL; Nakamura-Ishizu A; Yang H; Suda T
Cell Rep; 2019 Feb; 26(9):2316-2328.e6. PubMed ID: 30811983
[TBL] [Abstract][Full Text] [Related]
50. Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation.
Yang G; Huang SC; Wu JY; Benz EJ
Blood; 2008 Jan; 111(1):392-401. PubMed ID: 17715393
[TBL] [Abstract][Full Text] [Related]
51. Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma.
Braun CJ; Stanciu M; Boutz PL; Patterson JC; Calligaris D; Higuchi F; Neupane R; Fenoglio S; Cahill DP; Wakimoto H; Agar NYR; Yaffe MB; Sharp PA; Hemann MT; Lees JA
Cancer Cell; 2017 Oct; 32(4):411-426.e11. PubMed ID: 28966034
[TBL] [Abstract][Full Text] [Related]
52. Naturally occurring heterologous trans-splicing of adenovirus RNA with host cellular transcripts during infection.
Kikumori T; Cote GJ; Gagel RF
FEBS Lett; 2002 Jul; 522(1-3):41-6. PubMed ID: 12095616
[TBL] [Abstract][Full Text] [Related]
53. The spliceosome, a potential Achilles heel of MYC-driven tumors.
Anczuków O; Krainer AR
Genome Med; 2015 Oct; 7():107. PubMed ID: 26490253
[TBL] [Abstract][Full Text] [Related]
54. SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival.
Su H; Hu J; Huang L; Yang Y; Thenoz M; Kuchmiy A; Hu Y; Li P; Feng H; Zhou Y; Taghon T; Van Vlierberghe P; Qing G; Chen Z; Liu H
Nat Commun; 2018 Oct; 9(1):4281. PubMed ID: 30323192
[TBL] [Abstract][Full Text] [Related]
55. Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.
Shen L; Ma X; Wang Y; Wang Z; Zhang Y; Pham HQH; Tao X; Cui Y; Wei J; Lin D; Abeywanada T; Hardikar S; Halabelian L; Smith N; Chen T; Barsyte-Lovejoy D; Qiu S; Xing Y; Yang Y
Nat Commun; 2024 Apr; 15(1):2809. PubMed ID: 38561334
[TBL] [Abstract][Full Text] [Related]
56. MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors.
Urbanski L; Brugiolo M; Park S; Angarola BL; Leclair NK; Yurieva M; Palmer P; Sahu SK; Anczuków O
Cell Rep; 2022 Nov; 41(8):111704. PubMed ID: 36417849
[TBL] [Abstract][Full Text] [Related]
57. Cellular redox homeostasis maintained by malic enzyme 2 is essential for MYC-driven T cell lymphomagenesis.
Li W; Kou J; Zhang Z; Li H; Li L; Du W
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2217869120. PubMed ID: 37253016
[TBL] [Abstract][Full Text] [Related]
58. Identification of c-MYC SUMOylation by mass spectrometry.
Kalkat M; Chan PK; Wasylishen AR; Srikumar T; Kim SS; Ponzielli R; Bazett-Jones DP; Raught B; Penn LZ
PLoS One; 2014; 9(12):e115337. PubMed ID: 25522242
[TBL] [Abstract][Full Text] [Related]
59. Modulation of alternative splicing by antisense oligonucleotides.
Sazani P; Kole R
Prog Mol Subcell Biol; 2003; 31():217-39. PubMed ID: 12494768
[No Abstract] [Full Text] [Related]
60. Modulating the expression of disease genes with RNA-based therapy.
Wood M; Yin H; McClorey G
PLoS Genet; 2007 Jun; 3(6):e109. PubMed ID: 17604456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
